Advanced Oncotherapy Rapidly changing to commercial execution (Interview)

Advanced Oncotherapy plc (LON:AVO) is the topic of discussion when Dr Martin Hall Analyst at Hardman & Co joins DirectorsTalk. Martin talks us through the interesting developments being made at the company, commercial deals, brings us up to date with the LIGHT system and tells us his overall conclusion from his report and the company as an investment case.

Advanced Oncotherapy is a UK-based company focused on delivering a cost-effective proton-based radiotherapy solution called LIGHT. Based on ground-breaking technology developed and tested at world renowned CERN in Switzerland, the LIGHT system delivers an integrated proton radiotherapy system to treat cancer.

You might also enjoy reading  Shield Therapeutics translating positive signals into sales (VIDEO)
Find more news, interviews, share price & company profile here for:
Hardman & Co

Share this interview

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on whatsapp
Hardman & Co
Advanced Oncotherapy Rapidly changing to commercial execution (Interview)

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions